Blogg

  • Reset
4.24.25 | Policy
A Spring 2025 Policy Update from SWHR

SWHR highlights significant activity at the federal level, which developments could have the greatest impact on women’s health research, and what’s on the horizon. 

4.24.25 | Policy
Women’s Health Advocacy in Motion: From 2024 Success to 2025 Action

Over the past year, women’s health experienced a policy resurgence at the federal level, with heightened attention and advocacy driving […]

4.23.25 | Policy
SWHR Statement on Women’s Health Initiative Contract Terminations

SWHR is deeply concerned to learn that core funding for the Women’s Health Initiative (WHI)—one of the most comprehensive and influential research projects in women’s health—is slated for termination at the end of the fiscal year.

4.17.25 | Policy
SWHR Submits Outside Witness Testimony on FY 2026 Appropriations

4.15.25 | Policy
Role of Federal Landscape in Shaping the Future of Public Health and Medical Research

The first Policy Advisory Council meeting of the year brought together two distinguished experts who shared their insights on recent federal developments, applying their experience from roles in the federal government and in public health policy.

4.14.25 | Alzheimer's Disease
Early Signs, Lasting Impact: Policy Pathways in Alzheimer’s Disease Detection and Care

Alzheimer’s disease is a growing public health crisis in the United States, disproportionately impacting women, who are twice as likely […]

4.10.25 | Policy
SWHR Provides Comments on Center for Innovation & Value Research’s Draft “A Blueprint for Patient-Centered Value Research”

4.9.25 | Research and Clinical Trials
Transforming Women’s Health through Science and Sustainable Partnerships

The Society for Women’s Health Research (SWHR) is thrilled to be partnering with The Global Health Connector this fall to […]

4.7.25 | Policy
SWHR Sends Letter to FDA in Study of Sex Differences in the Clinical Evaluation of Medical Products

4.4.25 | Policy
SWHR Statement on NICHD Leadership Departure

The Society for Women’s Health Research issued the following statement in response to the announced departure of Diana Bianchi, MD, from the National Institutes of Health.